[September 16, 2016]

Cachexia Forecast in 8 Major Markets 2016-2026 - Analysis, Technologies & Forecasts Report - Research and Markets

Research and Markets has announced the addition of the "Cachexia Forecast in 8 Major Markets 2016-2026" report to their offering.

This report provides the current prevalent population Cachexia across 8 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of Cachexia have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Key underlying pathologies linked with developing cachexia include:

• COPD
• CKD and end stage renal diseae (ESRD)
• CHF
• Cancer
• AIDS and HIV
• Rheumatoid arthritis and other autoimmune conditions

• Able to quantify patient populations in the global Cachexia market to target the development of future products, pricing strategies and launch plans.
• Gain further insight into the prevalence of the subdivided types of Cachexia and identify patient segments with high potential.
• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
• Provide a level of understanding on the impact from specific co-morbid conditions on Cachexia's prevalent population.
• Identify sub-populations within Cachexia which require treatment.

Report Structure:

1. Introduction

2. Cause of the Disease

3. Risk Factors & Prevention

4. Diagnosis of the Disease

5. Variation by Geography/Ethnicity

6. Disease Prognosis (News - Alert) & Clinical Course

7. Key Co-morbid Conditions/Features Associated with the Disease

8. Methodology for Quantification of Patient Numbers

9. Top-Line Prevalence for Cachexia

10. Features of Cachexia Patients

11. Abbreviations used in the Report

12. Patient-Based Offering

13. Online Pricing Data and Platforms

14. References

15. Appendix

For more information about this report visit http://www.researchandmarkets.com/research/jwk278/cachexia_forecast

View source version on businesswire.com: http://www.businesswire.com/news/home/20160916005644/en/

[ Back To TMCnet.com's Homepage ]